Sur vs Tuvalu: Previously treated cases tested for RR-/MDR-TB
Sur
62.0%
in 2024
Tuvalu
100.0%
in 2021
Sur rank
1st
Tuvalu rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sur
- Tuvalu
How they compare
Tuvalu currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Tuvalu's figure about 1.6 times Sur's.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Sur ahead.
Sur ranks 1st and Tuvalu ranks 1st of 1 regions.
Across the 2 decades both report, Sur averaged higher in 1 and Tuvalu in 1.
Head to head by decade
| Decade | Sur | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 85.0% | 36.8% | 48.2% | Sur |
| 2020s | 75.0% | 100.0% | 25.0% | Tuvalu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sur or Tuvalu?
- Tuvalu, at 100.0% against 62.0% in Sur as of 2021.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sur and Tuvalu?
- 38.0%, with Tuvalu ahead.
- How many years of comparable data are there for Sur and Tuvalu?
- 6 years are reported by both, from 2014 to 2021.
- How do Sur and Tuvalu rank globally for previously treated cases tested for rr-/mdr-tb?
- Sur ranks 1st and Tuvalu ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.